Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents

L. D. Sabath

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The mechanisms involved in the susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents are varied. For the beta-lactam agents, susceptibility of the organism is dependent on penetration of the outer membrane, binding to target proteins, absence of significant beta-lactamases, and, possibly, the initiation of cell wall lysis. Susceptibility to aminoglycosides is based on membrane permeation and transport and specific binding to the 30S ribosomal subunit. Antipseudomonal activity of the polymyxins is related to their binding to membrane phospholipids, with subsequent disruption of the membrane; and activity of tetracycline and erythromycin, which is pH-dependent, affects protein synthesis. Resistance to beta-lactam agents is mediated through beta-lactamases, the Id and V enzymes being especially important in P. aeruginosa. Other postulated mechanisms of resistance include the presence of a permeability barrier, insensitivity of target sites, decreased binding, and "trapping." Decreased binding to the S12 protein (often termed the P10 protein in references to streptomycin), decreased active transport, and enzyme-mediated modification are the major mechanisms responsible for resistance to aminoglycosides. The factors involved in resistance to tetracycline and erythromycin remain unclear. The emergence of resistance during a single course of beta-lactam therapy is a special problem with P. aeruginosa and may be due to acquisition of resistance genes, cross-infection, selection or induction of resistance in some variants, or mutation. [References: 136]
Original languageUndefined/Unknown
Pages (from-to)S643-S656
JournalReviews of Infectious Diseases
Volume6
Issue numberSuppl 3
StatePublished - 1984

Keywords

  • Aminoglycosides/me [Metabolism]
  • Aminoglycosides/pd [Pharmacology]
  • Anti-Bacterial Agents/me [Metabolism]
  • Anti-Bacterial Agents/pd [Pharmacology]
  • Drug Resistance, Microbial
  • Humans
  • Lactams
  • Pseudomonas Infections/dt [Drug Therapy]
  • Pseudomonas Infections/mi [Microbiology]
  • Pseudomonas aeruginosa/de [Drug Effects]
  • Pseudomonas aeruginosa/ph [Physiology]

Cite this

Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents. / Sabath, L. D.

In: Reviews of Infectious Diseases, Vol. 6, No. Suppl 3, 1984, p. S643-S656.

Research output: Contribution to journalArticle

@article{08001c8c14354fe2921b2e5f4ae49a25,
title = "Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents",
abstract = "The mechanisms involved in the susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents are varied. For the beta-lactam agents, susceptibility of the organism is dependent on penetration of the outer membrane, binding to target proteins, absence of significant beta-lactamases, and, possibly, the initiation of cell wall lysis. Susceptibility to aminoglycosides is based on membrane permeation and transport and specific binding to the 30S ribosomal subunit. Antipseudomonal activity of the polymyxins is related to their binding to membrane phospholipids, with subsequent disruption of the membrane; and activity of tetracycline and erythromycin, which is pH-dependent, affects protein synthesis. Resistance to beta-lactam agents is mediated through beta-lactamases, the Id and V enzymes being especially important in P. aeruginosa. Other postulated mechanisms of resistance include the presence of a permeability barrier, insensitivity of target sites, decreased binding, and {"}trapping.{"} Decreased binding to the S12 protein (often termed the P10 protein in references to streptomycin), decreased active transport, and enzyme-mediated modification are the major mechanisms responsible for resistance to aminoglycosides. The factors involved in resistance to tetracycline and erythromycin remain unclear. The emergence of resistance during a single course of beta-lactam therapy is a special problem with P. aeruginosa and may be due to acquisition of resistance genes, cross-infection, selection or induction of resistance in some variants, or mutation. [References: 136]",
keywords = "Aminoglycosides/me [Metabolism], Aminoglycosides/pd [Pharmacology], Anti-Bacterial Agents/me [Metabolism], Anti-Bacterial Agents/pd [Pharmacology], Drug Resistance, Microbial, Humans, Lactams, Pseudomonas Infections/dt [Drug Therapy], Pseudomonas Infections/mi [Microbiology], Pseudomonas aeruginosa/de [Drug Effects], Pseudomonas aeruginosa/ph [Physiology]",
author = "Sabath, {L. D.}",
year = "1984",
language = "Undefined/Unknown",
volume = "6",
pages = "S643--S656",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "Suppl 3",

}

TY - JOUR

T1 - Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents

AU - Sabath, L. D.

PY - 1984

Y1 - 1984

N2 - The mechanisms involved in the susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents are varied. For the beta-lactam agents, susceptibility of the organism is dependent on penetration of the outer membrane, binding to target proteins, absence of significant beta-lactamases, and, possibly, the initiation of cell wall lysis. Susceptibility to aminoglycosides is based on membrane permeation and transport and specific binding to the 30S ribosomal subunit. Antipseudomonal activity of the polymyxins is related to their binding to membrane phospholipids, with subsequent disruption of the membrane; and activity of tetracycline and erythromycin, which is pH-dependent, affects protein synthesis. Resistance to beta-lactam agents is mediated through beta-lactamases, the Id and V enzymes being especially important in P. aeruginosa. Other postulated mechanisms of resistance include the presence of a permeability barrier, insensitivity of target sites, decreased binding, and "trapping." Decreased binding to the S12 protein (often termed the P10 protein in references to streptomycin), decreased active transport, and enzyme-mediated modification are the major mechanisms responsible for resistance to aminoglycosides. The factors involved in resistance to tetracycline and erythromycin remain unclear. The emergence of resistance during a single course of beta-lactam therapy is a special problem with P. aeruginosa and may be due to acquisition of resistance genes, cross-infection, selection or induction of resistance in some variants, or mutation. [References: 136]

AB - The mechanisms involved in the susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents are varied. For the beta-lactam agents, susceptibility of the organism is dependent on penetration of the outer membrane, binding to target proteins, absence of significant beta-lactamases, and, possibly, the initiation of cell wall lysis. Susceptibility to aminoglycosides is based on membrane permeation and transport and specific binding to the 30S ribosomal subunit. Antipseudomonal activity of the polymyxins is related to their binding to membrane phospholipids, with subsequent disruption of the membrane; and activity of tetracycline and erythromycin, which is pH-dependent, affects protein synthesis. Resistance to beta-lactam agents is mediated through beta-lactamases, the Id and V enzymes being especially important in P. aeruginosa. Other postulated mechanisms of resistance include the presence of a permeability barrier, insensitivity of target sites, decreased binding, and "trapping." Decreased binding to the S12 protein (often termed the P10 protein in references to streptomycin), decreased active transport, and enzyme-mediated modification are the major mechanisms responsible for resistance to aminoglycosides. The factors involved in resistance to tetracycline and erythromycin remain unclear. The emergence of resistance during a single course of beta-lactam therapy is a special problem with P. aeruginosa and may be due to acquisition of resistance genes, cross-infection, selection or induction of resistance in some variants, or mutation. [References: 136]

KW - Aminoglycosides/me [Metabolism]

KW - Aminoglycosides/pd [Pharmacology]

KW - Anti-Bacterial Agents/me [Metabolism]

KW - Anti-Bacterial Agents/pd [Pharmacology]

KW - Drug Resistance, Microbial

KW - Humans

KW - Lactams

KW - Pseudomonas Infections/dt [Drug Therapy]

KW - Pseudomonas Infections/mi [Microbiology]

KW - Pseudomonas aeruginosa/de [Drug Effects]

KW - Pseudomonas aeruginosa/ph [Physiology]

M3 - Article

C2 - 6443766

VL - 6

SP - S643-S656

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - Suppl 3

ER -